membran
fusion
induc
envelop
glycoprotein
enabl
intracellular
replic
henc
process
constitut
major
target
antiretrovir
compound
propos
peptid
propens
interact
membran
interfac
might
exert
broad
antivir
activ
envelop
virus
test
hypothesi
contribut
analyz
antivir
effect
peptid
deriv
membraneproxim
extern
region
transmembran
domain
envelop
glycoprotein
subunit
display
differ
degre
interfaci
hydrophob
data
support
virucid
activ
region
combin
hydrophobicatinterfac
membraneproxim
extern
region
aromat
hydrophob
residu
transmembran
domain
contain
absolut
conserv
lwyikr
sequenc
propos
embodi
cholesterol
recognitioninteract
amino
acid
consensu
motif
sought
correl
antivir
activ
peptid
effect
membran
mimic
lipid
composit
biophys
properti
viral
envelop
data
reveal
peptid
endow
virucid
activ
membran
activ
induc
permeabil
fusion
viruslik
lipid
vesicl
addit
modul
lipid
pack
miscibl
later
segreg
liquid
domain
two
properti
depend
high
cholesterol
content
viral
membran
thu
overal
experiment
evid
consist
pattern
hiv
inhibit
involv
direct
alter
physic
chemistri
viru
membran
furthermor
sequencedepend
effect
observ
might
guid
develop
new
virucid
peptid
among
major
drug
class
approv
human
immunodefici
viru
hiv
antiretrovir
therapi
entri
inhibitor
uniqu
block
function
extracellular
target
envelop
glycoprotein
env
env
subunit
surfac
transmembran
respons
receptorcoreceptor
bind
viruscel
fusion
respect
upon
activ
fusion
process
ectodomain
trimer
refold
lowenergi
bundl
pull
cell
viru
membran
close
contact
conform
transit
undergon
trimer
constitut
target
clinic
approv
fusion
inhibitor
enfuvirtid
block
bundl
complet
henc
membran
merger
develop
altern
fusion
inhibitor
display
broad
sustain
antiretrovir
activ
remain
pursu
goal
date
recent
propos
membranetarget
virucid
compound
may
compris
broadspectrum
inhibitor
envelop
viru
entri
arguabl
compound
interf
fusion
act
lipid
compon
viral
envelop
could
provid
basi
escapeproof
antivir
therapi
addit
oppos
host
cell
membran
subject
ongo
synthesi
degrad
influx
efflux
compon
static
viral
membran
lack
repair
mechan
escap
major
perturb
induc
virucid
activ
regard
seri
work
support
possibl
peptid
deriv
hydrophobicatinterfac
envelop
glycoprotein
sequenc
may
compris
new
gener
antivir
along
line
think
recent
review
contend
virucid
peptid
could
block
viral
entri
chang
directli
physic
chemistri
viral
membran
upon
partit
recent
establish
synthet
viruslik
vl
mixtur
includ
main
seven
lipid
speci
found
membran
exhibit
order
degre
phase
behavior
term
previou
report
get
new
insight
molecular
mechan
govern
antivir
activ
membranepartit
peptid
first
compar
inhibitori
potenc
sever
membraneproxim
extern
regiontransmembran
domain
mpertmd
deriv
peptid
possess
distinct
interfaci
hydrophob
pattern
establish
membranerestructur
capac
use
vl
mixtur
surrog
hiv
membran
experiment
data
support
virucidelik
activ
alter
physic
chemistri
hiv
lipid
envelop
peptid
combin
hydrophobicatinterfac
ctermin
mper
sequenc
ntermin
hydrophob
section
tmd
specul
sequenc
may
serv
platform
develop
antiretrovir
peptid
popc
pope
pop
cholesterol
chol
egg
sphingomyelin
sm
contain
npalmitoyl
sm
dodecanoyl
dihydrosphingomyelin
dhsm
plasmologen
pe
plpe
purchas
avanti
polar
lipid
alabast
al
acid
sodium
salt
ant
pxylenebi
pyridinium
bromid
dpx
n
phosphatidylethanolamin
n
lissamin
rhodamin
b
sulfonyl
phosphatidylethanolamin
laurdan
obtain
molecular
probe
eugen
phospholipid
stock
concentr
determin
phosphat
assay
collect
peptid
display
fig
b
synthes
ctermin
carboxamid
form
solidphas
method
use
fmoc
chemistri
purifi
reversephas
highperform
liquid
chromatographi
character
matrixassist
laser
desorpt
ionizationtimeofflight
mass
spectrometri
puriti
cellentri
assay
perform
measur
green
fluoresc
protein
gfp
gene
transduct
accord
bobardt
et
al
modif
describ
markosyan
et
al
brief
pseudovirus
produc
transfect
human
kidney
cell
fulllength
env
clone
jrcsf
kindli
provid
jami
k
scott
nave
gulzar
simon
fraser
univers
burnabi
british
columbia
canada
use
calcium
phosphat
cell
cotransfect
vector
pwxlpgfp
encod
gfp
envdefici
genom
respect
provid
patricia
villac
csic
madrid
spain
h
medium
replac
optimemglutamax
ii
invitrogen
paisley
uk
without
serum
two
day
transfect
pseudoviru
particl
harvest
pass
steril
filter
millexhv
millipor
nv
brussel
belgium
final
concentr
ultracentrifug
sucros
gradient
hiv
entri
determin
use
tzmbl
target
cell
aid
research
refer
reagent
program
divis
aid
nation
institut
allergi
infecti
diseas
nation
institut
health
bethesda
md
contribut
j
kapp
hiv
pseudovirus
dilut
tissu
cultur
infecti
dose
pb
deposit
onto
polyllysineco
plate
incub
c
min
wash
free
polylysin
block
min
medium
addit
dmem
fb
c
sever
dilut
given
peptid
pb
subsequ
appli
min
c
three
wash
step
larg
unilamellar
vesicl
luv
made
vl
lipid
mixtur
popc
spmcholdhsmpopeplpepop
mol
ratio
produc
follow
extrus
method
end
lipid
suspens
subject
freezethaw
cycl
extrus
time
two
stack
polycarbon
membran
nomin
pores
mm
nucleopor
pleasanton
ca
vesicl
permeabl
chang
vesiclevesicl
fusion
determin
standard
assay
antsdpx
leakag
rhopenbdpebas
lipid
mix
respect
giant
unilamellar
vesicl
guv
produc
spontan
swell
follow
procedur
describ
prepar
peptidecontain
guv
lipid
mg
vl
lipid
mixtur
peptid
mix
desir
peptidetolipid
molar
ratio
chcl
ch
oh
desicc
h
remov
organ
solvent
dri
silica
bead
cover
lipidpeptid
mixtur
collect
transfer
gl
sucros
buffer
induc
spontan
swell
guv
form
vesicl
transfer
observ
dish
isosmot
mm
hepe
mm
kcl
ph
buffer
imag
acquir
tc
ii
microscop
leica
microsystem
wetzlar
germani
describ
laurdanstain
guv
excit
nm
use
waterimmers
object
numer
apertur
pixel
imag
acquir
hz
per
scan
line
fluoresc
emiss
simultan
imag
nm
nm
gener
polar
gp
imag
comput
everi
pixel
imag
eq
b
intens
blue
channel
r
intens
green
channel
g
factor
account
rel
sensit
two
channel
calibr
mm
laurdan
solut
pure
dmso
c
produc
planarsupport
phospholipid
layer
phospholipid
monolay
first
spread
chloroformmethanol
vv
solut
onto
mm
tri
ph
mm
nacl
subphas
thermost
langmuirblodgett
trough
nima
technolog
coventri
uk
transfer
onto
mica
describ
afm
imag
obtain
nanowizard
ii
atom
forc
microscop
jpk
instrument
berlin
germani
describ
huart
et
al
plot
fig
display
distribut
wimleywhit
interfaci
hydrophob
along
mpertmd
region
nterminu
amphipathicatinterfac
helix
residu
follow
fulli
hydrophobicatinterfac
stretch
residu
support
biolog
relev
mper
segment
consecut
span
broadli
neutral
epitop
interfaci
sequenc
follow
tmd
residu
mostli
hydrophob
accord
kytedoolittl
hydropathi
index
tmd
also
segment
two
subdomain
due
presenc
midway
polar
residu
interestingli
mper
ctermin
tmd
ntermin
subregion
part
continu
helix
final
residu
lwyik
mpertmd
junctur
propos
embodi
cholesterol
recognitioninteract
amino
acid
consensu
crac
motif
region
absolut
conserv
across
viral
strain
isol
would
involv
gener
type
lipid
perturb
prime
rigid
viral
membran
fusion
particular
organ
mpertmd
region
allow
one
hand
test
predict
cracmedi
choldepend
membran
perturb
may
sustain
antivir
activ
deriv
peptid
hand
one
assess
effect
combin
distinct
hydrophob
pattern
inhibitori
potenc
peptid
sequenc
rang
cover
peptid
display
panel
fig
b
thu
select
basi
presenc
crac
motif
hydrophob
profil
list
includ
peptid
bear
ile
residu
posit
absolut
conserv
residu
result
substitut
shown
attenu
interact
cracrepres
peptid
chol
reduc
env
fusogen
fig
b
compar
antivir
activ
peptid
effect
exert
vl
luv
leakag
fusion
antivir
activ
evalu
virion
first
attach
polylysineco
plate
see
fig
cell
infect
subsequ
quantifi
follow
procedur
describ
bobardt
et
al
amphipathicatinterfac
peptid
mper
display
b
figur
design
hydrophobicatinterfac
peptid
antivir
membranerestructur
activ
given
hydrophob
distribut
within
mpertmd
region
top
amino
acid
sequenc
bottom
calcul
mean
ww
hydrophob
kd
hydropathi
window
five
amino
acid
use
wwh
kdh
respect
dot
line
repres
ww
moment
window
amino
acid
calcul
fix
helic
period
use
hydrophobicityatinterfac
scale
cylind
sequenc
highlight
helic
subdomain
connect
nonhel
joint
posit
postul
crac
motif
also
indic
b
shown
sequenc
cover
overlap
peptid
use
studi
effect
pseudoviru
infect
vesicl
permeabl
vesiclevesicl
fusion
left
center
right
panel
respect
cell
entri
inhibit
assay
pseudovirus
preattach
lysineco
plate
treat
increas
concentr
peptid
indic
panel
wash
report
tzmbl
cell
layer
top
infect
infer
number
total
cell
express
gfp
fig
see
figur
color
go
onlin
signific
antihiv
activ
mm
rang
fig
b
left
panel
addit
interfaci
hydrophob
crac
motif
c
terminu
render
peptid
mper
elicit
activ
thu
appear
bear
high
interfaci
hydrophob
suffici
trigger
virucid
activ
even
peptid
contain
crac
sequenc
contrast
peptid
mper
combin
ctermin
hydrophobicatinterfac
mper
stretch
ntermin
section
tmd
induc
robust
antivir
activ
mean
ic
valu
mm
interestingli
peptid
mper
mutat
crac
motif
display
compar
virucid
effect
ic
valu
mm
final
tmd
sequenc
repres
fulllength
tmd
defin
cohen
et
al
appar
effect
pseudoviru
cell
entri
ascertain
whether
infectionblock
effect
observ
case
peptid
mper
mper
due
virucidetyp
activ
consequ
specif
inhibit
envmedi
entryfus
experi
also
conduct
virion
pseudotyp
vsv
g
glycoprotein
vsvg
fig
b
incub
vsvg
pseudovirus
peptid
result
compar
level
infect
block
therebi
support
virucidelik
behavior
inhibitori
peptid
rather
activ
depend
sequencespecif
mechan
determin
observ
virucid
activ
correl
capac
peptid
alter
properti
viral
membran
use
sevenlipid
vl
mixtur
envelop
surrog
first
assay
leakag
lipid
mix
induc
peptid
vl
luv
fig
b
center
right
panel
respect
signific
leakag
content
lipid
mix
observ
upon
vl
luv
incub
mper
mper
peptid
interestingli
tmd
peptid
also
induc
lipid
mix
observ
consist
data
previous
report
literatur
see
recent
review
thu
vl
vesicl
destabil
correl
observ
virucid
effect
peptid
mper
mper
howev
peptideinduc
perturb
vesicular
system
relax
vesiclevesicl
aggreg
fusion
must
persist
immobil
viral
particl
use
infect
assay
fig
control
experi
also
indic
lipid
solubil
extract
virion
treat
inhibitori
peptid
fig
thu
hypothes
local
perturb
lead
luv
leakag
fusion
may
affect
interrel
way
addit
physicochem
properti
lipid
envelop
immobil
virion
hiv
particl
enrich
chol
mol
underpin
increas
membran
order
potenti
liquid
phase
coexist
lipid
extract
infecti
viru
particl
vl
surrog
actual
display
high
lipid
pack
level
later
demix
nanodomain
therefor
identifi
addit
effect
might
correl
viru
inactiv
cell
infect
assay
next
evalu
chang
choldepend
lipid
pack
later
organ
induc
peptid
mper
mper
fig
lipid
pack
first
determin
quantit
twophoton
imag
laurdanstain
vl
guv
fig
laurdan
fluoresc
emiss
undergo
larg
spectral
shift
due
reorient
polar
molecul
fluorophor
vicin
time
spend
excit
state
incorpor
lipid
bilay
laurdan
fluoresc
emiss
function
hydrat
viscos
membran
reflect
phase
state
wavelengthratiometr
paramet
call
gener
polar
gp
eq
quantifi
laurdan
emiss
spectral
shift
tightli
pack
low
water
content
high
gp
valu
loos
pack
high
water
content
low
gp
valu
bilay
thu
provid
indirect
measur
membran
order
pack
assumpt
lwyik
sequenc
interact
sequest
chol
effect
deplet
compound
mixtur
assess
parallel
gp
imag
differ
vl
guv
sampl
display
singl
macroscop
phase
fig
reflect
normal
unimod
distribut
pixelgp
valu
everi
guv
expect
decreas
chol
content
result
lower
mean
gp
valu
consist
decreas
vl
membran
order
fig
b
left
panel
subtl
reduct
laurdan
gp
valu
observ
guv
treat
peptid
mper
mper
fig
b
right
panel
furthermor
score
gp
reduct
compar
two
peptid
suggest
preserv
crac
motif
requir
fluidifi
effect
next
compar
capac
peptid
alter
liquidliquid
miscibl
vl
membran
nanoscal
fig
langmuirblodgett
film
compress
mnm
transfer
onto
mica
analyz
afm
caution
vl
lipid
monolay
use
model
system
allow
comparison
potenti
differ
interfaci
peptid
modifi
choldepend
liquidliquid
miscibl
highlight
support
monolay
experiment
condit
limit
sens
mimic
actual
envelop
therefor
use
tool
tackl
specif
question
lipidpeptid
interplay
observ
phenomena
provid
addit
insight
action
mechan
mpertmdderiv
antivir
peptid
result
display
fig
reveal
demix
nanoscop
domain
untreat
vl
lipid
monolay
upon
reduct
chol
content
nanodomain
retain
rough
boundari
convolut
morpholog
featur
consist
low
line
tension
domain
interfac
condit
inclus
peptid
mper
mper
lipid
mixtur
peptidetolipid
mole
ratio
result
case
segreg
much
larger
lipid
platform
limit
smooth
contour
observ
lipid
monolay
contain
lower
amount
chol
line
tension
rim
demix
phase
intensifi
height
differ
rigid
domain
surround
membran
region
dh
increas
high
interfaci
energi
reduc
coalesc
perimet
minim
rigid
domain
valu
dh
paramet
increas
upon
chol
deplet
mixtur
fig
b
left
panel
howev
consist
smoother
contour
larger
domain
size
dh
valu
significantli
higher
peptidecontain
monolay
fig
b
right
panel
thu
inclus
mol
peptid
induc
mark
effect
lipid
miscibl
reduc
chol
content
mixtur
mol
togeth
fact
presenc
function
crac
requir
induc
effect
data
clearli
indic
observ
alter
consequ
peptideinduc
chol
deplet
format
equimolar
peptidechol
complex
conclus
previou
result
suggest
mper
peptid
requir
establish
direct
interact
chol
crac
motif
alter
lipid
pack
lipidlipid
miscibl
gain
insight
mechan
mper
exert
antivir
activ
next
compar
effect
produc
inact
mpertmd
sequenc
fig
fig
illustr
effect
peptid
lipid
pack
infer
laurdan
gp
determin
singl
vesicl
experi
peptid
lipid
mix
defin
mol
ratio
desicc
silica
bead
data
reveal
slight
decreas
mean
gp
valu
guv
contain
virucid
peptid
mper
compar
decreas
guv
contain
inact
peptid
mper
mper
tmd
differ
activ
inact
sequenc
becam
appar
nanoscop
level
fig
b
besid
segreg
larg
lipid
platform
afm
measur
disclos
sampl
contain
mper
accumul
materi
fluid
area
also
contact
condens
fluid
domain
arrowhead
lipid
monolay
contain
inact
peptid
display
distinct
nanostructur
larg
segreg
platform
accumul
materi
could
discern
sampl
contain
mper
peptid
contrast
segreg
domain
could
observ
monolay
contain
mper
peptid
although
sampl
materi
observ
accumul
fluid
area
materi
detect
peripheri
rigid
domain
final
liquidliquid
immisc
also
observ
sampl
contain
tmd
peptid
case
pattern
complet
differ
rigid
area
surround
stream
fluid
lipid
height
differ
domain
display
bottom
panel
emphas
substanti
effect
induc
activ
peptid
mper
thu
appear
capabl
accumul
edg
lipid
domain
alter
line
tension
distinct
properti
activ
mper
sequenc
measur
height
differ
segreg
domain
vl
monolay
display
fig
support
idea
consist
intrins
activ
peptid
data
indic
mper
effect
line
tension
doseand
timedepend
fig
b
respect
basi
broad
antivir
activ
display
hydrophob
andor
amphipath
peptid
well
understood
two
factor
emphas
suitabl
hiv
envelop
target
compon
type
peptid
hiv
particl
cover
solventaccess
lipid
bilay
mostli
devoid
protein
preserv
chemic
composit
biophys
properti
lipid
bilay
seem
critic
entri
function
addit
env
subunit
anchor
hiv
membran
mpertmd
region
env
residu
number
encompass
interfaci
activ
sequenc
enrich
aromat
residu
map
potenti
virucid
activ
within
mpertmd
region
work
employ
sever
overlap
peptid
featur
differ
degre
interfaci
hydrophob
fig
furthermor
use
vl
surrog
compar
assess
select
peptid
capac
alter
membran
stabil
well
modul
choldepend
lipid
pack
liquidliquid
miscibl
follow
summar
observ
discuss
relat
mper
virucid
activ
provid
knowledg
new
insight
mechan
action
hydrophobicatinterfac
antivir
peptid
compar
assess
mpertmdderiv
peptid
identifi
sequenc
mper
inhibit
hiv
infect
ic
mm
fig
fact
similar
inhibit
pattern
observ
vsv
pseudovirus
fig
support
virucidelik
activ
peptid
preserv
interfaci
hydrophob
although
requir
suffici
elicit
activ
peptid
mper
combin
within
singl
construct
amphipathicatinterfac
fulli
hydrophobicatinterfac
section
virucid
antivir
capac
attain
fulli
hydrophob
peptid
tmd
either
notabl
peptid
mper
display
virucid
efficaci
combin
hydrophobicatinterfac
aromat
hydrophobicaliphat
residu
antivir
activ
peptid
mper
alter
induc
membran
also
requir
intact
crac
motif
fig
b
strongli
suggest
virucid
effect
depend
direct
interact
peptid
chol
fact
observ
mol
peptid
induc
lipid
demix
augment
line
tension
effici
reduc
chol
content
mol
exclud
possibl
mper
act
deplet
compound
fig
compar
inact
peptid
mper
sequenc
endow
antivir
activ
destabil
sevenlipid
vl
membran
caus
signific
luv
permeabil
ant
leakag
fusion
lipid
mix
fig
b
thu
virucid
peptid
display
membran
activ
lipid
mixtur
resembl
composit
biophys
properti
viral
envelop
howev
mechan
relat
membran
activ
infect
inhibit
clear
one
plausibl
mechan
explain
inhibitori
effect
mper
could
gener
solubil
disaggreg
viral
envelop
peptid
either
follow
detergentlik
mechan
extract
lipid
describ
choldeplet
compound
bcyclodextrin
howev
control
experi
condit
emul
infect
assay
ie
isol
virion
immobil
onto
solid
substrat
fig
indic
incub
peptid
remov
membran
lipid
fig
top
contrast
treatment
sampl
deterg
triton
choldeplet
bcyclodextrin
total
partial
deplet
solid
support
lipid
respect
fig
bottom
fact
immobil
viral
particl
remain
isol
cell
infect
experiment
setup
fig
also
b
figur
height
differ
demix
domain
surround
lipid
surfac
induc
mper
vl
monolay
function
peptidetolipid
mole
ratio
time
inject
subphas
b
mannwhitney
test
p
p
p
signific
ns
r
rule
virionvirion
aggregationfus
induc
peptid
mechan
underli
virucid
activ
thu
infer
perturb
result
membran
permeabil
intervesicl
lipid
mix
might
also
affect
addit
biophys
properti
membran
isol
virion
whose
preserv
requir
sustain
infect
high
quantiti
chol
incorpor
viral
membran
hiv
assembl
wherea
deplet
compound
inactiv
viru
argu
high
level
lipid
pack
induc
chol
requir
preserv
function
hiv
particl
observ
virucid
peptid
mper
mper
slightli
although
significantli
decreas
lipid
pack
vl
mixtur
fig
howev
compar
fluidifi
effect
observ
inact
sequenc
mper
tmd
incorpor
vl
guv
fig
thu
gener
slight
fluidif
viral
membran
seem
explain
virucid
activ
mper
chol
level
also
modul
liquidliquid
miscibl
vl
mixtur
fig
approach
effect
mpertmdderiv
peptid
later
segreg
use
lipid
monolay
compress
mnm
repres
miscibl
transit
pressur
hiv
lipid
ternari
mixtur
contain
chol
condit
also
select
base
previou
observ
indic
increas
later
pressur
mnm
induc
collaps
lipid
monolay
made
viral
lipid
wherea
later
organ
consist
demix
nanodomain
preserv
lower
valu
mnm
thu
afm
analysi
vl
lipid
monolay
allow
score
nanoscop
length
scale
effect
differ
peptid
demix
liquid
domain
pattern
fig
topograph
inform
obtain
experiment
condit
confirm
activ
peptid
mper
induc
nanodomain
cluster
howev
similar
effect
observ
inact
peptid
mper
tmd
thu
capac
peptid
induc
nanodomain
cluster
seem
explain
observ
virucid
activ
afm
analys
lipid
monolay
also
reveal
accumul
materi
rim
rigid
domain
vl
monolay
contain
mper
virucid
peptid
pattern
observ
case
inact
peptid
fig
b
addit
activ
peptid
induc
highest
measur
domain
height
differ
nanodomain
cluster
fig
b
observ
suggest
comparison
inact
peptid
mper
alter
line
tension
directli
accumul
peripheri
rigid
domain
data
provid
conclus
evid
support
virucid
activ
peptid
deriv
mpertmd
region
mechan
action
involv
chang
physic
chemistri
viru
membran
compar
analysi
identifi
two
properti
virucid
sequenc
robustli
correl
inhibitori
activ
faculti
permeabil
vl
luv
potenti
accumul
peripheri
rigid
domain
modul
line
tension
effect
interrel
accumul
edg
lipid
domain
might
help
assembl
membran
permeat
structur
induc
vesicl
leakag
previous
shown
case
poreform
toxin
establish
correl
among
interfaci
activ
membran
activ
antivir
activ
function
sequenc
hydrophob
pattern
might
help
futur
develop
virucid
peptid
two
figur
avail
http
wwwbiophysjorgbiophysjsupplement
